HeraMED Limited (ASX:HMD)
0.0430
+0.0010 (2.38%)
Oct 7, 2026, 3:24 PM AEST
HeraMED Market Cap
HeraMED has a market cap or net worth of 49.82 million as of October 7, 2026. That makes HeraMED the world's 33,160th most valuable company and 809th in Australia. Its market cap has increased by 22.71% in one year.
Market Cap
49.82M
Enterprise Value
46.89M
Revenue
330.44K
Global Rank
Country Rank
#809 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since December 12, 2018, HeraMED's market cap has increased from 15.76M to 49.82M, an increase of 216.22%. That is a compound annual growth rate of 15.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 49.82M | 29.31% |
| Dec 31, 2025 | 38.53M | 120.00% |
| Dec 31, 2024 | 17.51M | 127.12% |
| Dec 29, 2023 | 7.71M | -74.58% |
| Dec 30, 2022 | 30.33M | -32.86% |
| Dec 31, 2021 | 45.18M | 173.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lumos Diagnostics Holdings | 94.48M |
| Cyclopharm | 64.75M |
| Epiminder | 63.92M |
| SomnoMed | 63.73M |
| Compumedics | 51.94M |
| Cleo Diagnostics | 43.88M |
| CleanSpace Holdings | 39.68M |
| Nova Eye Medical | 38.46M |